Efficacy and Safety of CD38 Monoclonal Antibodies in Multiple Myeloma: a Meta-analysis

Efficacy and Safety of CD38 Monoclonal Antibodies in Multiple Myeloma: a Meta-analysis

Background Multiple myeloma is a malignant disease in which plasma cells abnormally proliferate in the bone marrow. Most patients may experience relapse/refractory and drug resistance with an unsatisfactory prognosis. CD38 monoclonal antibodies have been reported to achieve durable remission in pati...

Full description

Bibliographic Details
Main Author: Ke LI, Zheng LI, Hui GENG, Jie MA
Format: Article
Language:zho
Published: Chinese General Practice Publishing House Co., Ltd 2022-07-01
Series:Zhongguo quanke yixue
Subjects:
multiple myeloma|hematologic neoplasms|antineoplastic agents, immunological|treatment outcome|safety|drug-related side effects and adverse reactions|meta analysis
Online Access:https://www.chinagp.net/fileup/1007-9572/PDF/zx2021120581.pdf

Internet

https://www.chinagp.net/fileup/1007-9572/PDF/zx2021120581.pdf

Similar Items